# Oncotec invests €35 million in robot-controlled filling line at Dessau site

Oncotec, a medac subsidiary, unveiled a €35 million investment in a robot-controlled filling line and automatic visual inspection system for syringes at its BioPharmaPark site in Dessau-Rosslau, Germany.

- Type: Investment
- Announced: 2019-09-11
- Where: Dessau-Rosslau, Saxony-Anhalt, Germany
- Value: $38.5M (35.0M EUR)
- Starts operating: 11 Sep 2019
- Status: completed
- Products: liquid cytostatics, pharmaceuticals for cancer and autoimmune diseases
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Oncotec](https://endata.com/companies/42040.md)
- [medac](https://endata.com/companies/42041.md) (partner)

## Sources

- [merz.com](https://www.merz.com/blog/news/merz-and-oncotec-make-major-investments-in-dessau-biopharmapark/), 2019-09-11: "With these new installations, Oncotec is more than ready to meet the future demands and dynamic global developments in drug manufacturing at our pharma site in Dessau."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.